fludeoxyglucose f18

Generic: fludeoxyglucose f-18

Labeler: biomedical research foundation of northwest louisiana
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fludeoxyglucose f18
Generic Name fludeoxyglucose f-18
Labeler biomedical research foundation of northwest louisiana
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

fludeoxyglucose f-18 300 mCi/mL

Manufacturer
Biomedical Research Foundation of Northwest Louisiana

Identifiers & Regulatory

Product NDC 24562-003
Product ID 24562-003_2f27bdce-6ab3-43e8-8eca-5192334e5280
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203837
Listing Expiration 2026-12-31
Marketing Start 2015-05-14

Pharmacologic Class

Established (EPC)
radioactive diagnostic agent [epc]
Mechanism of Action
radiopharmaceutical activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24562003
Hyphenated Format 24562-003

Supplemental Identifiers

UNII
0Z5B2CJX4D
NUI
N0000177914 N0000000205

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fludeoxyglucose f18 (source: ndc)
Generic Name fludeoxyglucose f-18 (source: ndc)
Application Number ANDA203837 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 300 mCi/mL
source: ndc
Packaging
  • 30 mL in 1 VIAL, GLASS (24562-003-30)
source: ndc

Packages (1)

24562-003-30 30 mL in 1 VIAL, GLASS (24562-003-30)

Ingredients (1)

fludeoxyglucose f-18 (300 mCi/mL)

Linked Drug Pages (1)

Fludeoxyglucose F18 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2f27bdce-6ab3-43e8-8eca-5192334e5280", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["edb15e3c-848d-433d-9f1c-c73a3c72861b"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["Biomedical Research Foundation of Northwest Louisiana"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, GLASS (24562-003-30)", "package_ndc": "24562-003-30", "marketing_start_date": "20150514"}], "brand_name": "Fludeoxyglucose F18", "product_id": "24562-003_2f27bdce-6ab3-43e8-8eca-5192334e5280", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "24562-003", "generic_name": "Fludeoxyglucose F-18", "labeler_name": "Biomedical Research Foundation of Northwest Louisiana", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fludeoxyglucose F18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "300 mCi/mL"}], "application_number": "ANDA203837", "marketing_category": "ANDA", "marketing_start_date": "20150514", "listing_expiration_date": "20261231"}